TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 19 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $150,000 | -86.6% | 254,330 | -11.5% | 0.00% | -100.0% |
Q2 2018 | $1,122,000 | +246.3% | 287,300 | +166.0% | 0.00% | – |
Q1 2018 | $324,000 | +25.6% | 108,000 | +44.4% | 0.00% | – |
Q4 2017 | $258,000 | +44.1% | 74,800 | +90.8% | 0.00% | – |
Q3 2017 | $179,000 | -20.4% | 39,200 | -18.6% | 0.00% | – |
Q1 2017 | $225,000 | – | 48,151 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 699,500 | $3,113,000 | 0.02% |
DRW Securities, LLC | 20,000 | $89,000 | 0.01% |
SG Americas Securities, LLC | 13,500 | $60,000 | 0.00% |
Winch Advisory Services, LLC | 300 | $1,000 | 0.00% |
Renaissance Technologies | 287,300 | $1,122,000 | 0.00% |
DIMENSIONAL FUND ADVISORS LP | 54,850 | $244,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 270 | $1,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 4,500 | $20,000 | 0.00% |
NORTHERN TRUST CORP | 12,480 | $56,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 38,714 | $172,000 | 0.00% |